Bevacizumab/Carboplatin/Paclitaxel/Pembrolizumab Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of bevacizumab, carboplatin, paclitaxel and pembrolizumab that may be used in the treatment of cervical, vulvar, and vaginal cancer.

**Synonyms:** - Avastin/Carboplatin/Taxol/Keytruda - Bevacizumab-Carboplatin-Paclitaxel-Pembrolizumab - Bevacizumab/Carboplatin/Paclitaxel/Pembrolizumab - Carboplatin and Paclitaxel (CP), Bevacizumab, Pembrolizumab - Carboplatin and Paclitaxel (CP), Bevacizumab-adcd, Pembrolizumab - Carboplatin and Paclitaxel (CP), Bevacizumab-awwb, Pembrolizumab - Carboplatin and Paclitaxel (CP), Bevacizumab-aybi, Pembrolizumab - Carboplatin and Paclitaxel (CP), Bevacizumab-bvzr, Pembrolizumab - Carboplatin and Paclitaxel (CP), Bevacizumab-equi, Pembrolizumab - Carboplatin and Paclitaxel (CP), Bevacizumab-maly, Pembrolizumab - Carboplatin and Paclitaxel (CP), Bevacizumab-onbe, Pembrolizumab - Carboplatin and Paclitaxel (CP), Bevacizumab-tnjn, Pembrolizumab - Paclitaxel/Carboplatin Plus Pembrolizumab/Bevacizumab